The Slovene Ministry of Health is planning to save millions of euros a year by introducing new legislation on prescription-drug prices. 524.5 million euros ($678.5 million) is annually spent on prescription drugs at hospitals in the Balkan state.
However, under new regulations that the Ministry claims will make drug pricing more transparent, it hopes to save 24.0 euros million annually.
The legislation will provide for setting prices through a comparison of prices in three selected countries - France, Germany and Austria. The important change from the previous system of pricing is that prices will be regulated at the level of producers, while wholesale margins will be fixed. Supporters of the regulation say that the change will make the regulation of prices up to a drug's arrival at a hospital or pharmacy more simple and transparent.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze